What is the right dosage of dasatinib for treating chronic myeloid leukaemia?

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Hehlmann, Rüdiger (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2021
In: British journal of haematology
Year: 2021, Jahrgang: 194, Heft: 2, Pages: 234
ISSN:1365-2141
DOI:10.1111/bjh.17618
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1111/bjh.17618
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17618
Volltext
Verfasserangaben:Rüdiger Hehlmann

MARC

LEADER 00000caa a2200000 c 4500
001 1840001712
003 DE-627
005 20230707010006.0
007 cr uuu---uuuuu
008 230324s2021 xx |||||o 00| ||eng c
024 7 |a 10.1111/bjh.17618  |2 doi 
035 |a (DE-627)1840001712 
035 |a (DE-599)KXP1840001712 
035 |a (OCoLC)1389537990 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hehlmann, Rüdiger  |d 1941-  |e VerfasserIn  |0 (DE-588)1037003489  |0 (DE-627)751737879  |0 (DE-576)390939463  |4 aut 
245 1 0 |a What is the right dosage of dasatinib for treating chronic myeloid leukaemia?  |c Rüdiger Hehlmann 
264 1 |c 2021 
300 |a 1 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 24.03.2023 
773 0 8 |i Enthalten in  |t British journal of haematology  |d Oxford [u.a.] : Wiley-Blackwell, 1955  |g 194(2021), 2, Seite 234  |h Online-Ressource  |w (DE-627)269758941  |w (DE-600)1475751-5  |w (DE-576)09113997X  |x 1365-2141  |7 nnas  |a What is the right dosage of dasatinib for treating chronic myeloid leukaemia? 
773 1 8 |g volume:194  |g year:2021  |g number:2  |g pages:234  |g extent:1  |a What is the right dosage of dasatinib for treating chronic myeloid leukaemia? 
856 4 0 |u https://doi.org/10.1111/bjh.17618  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17618  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20230324 
993 |a Article 
994 |a 2021 
998 |g 1037003489  |a Hehlmann, Rüdiger  |m 1037003489:Hehlmann, Rüdiger  |d 60000  |d 61200  |e 60000PH1037003489  |e 61200PH1037003489  |k 0/60000/  |k 1/60000/61200/  |p 1  |x j  |y j 
999 |a KXP-PPN1840001712  |e 4296636456 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Rüdiger Hehlmann"]},"language":["eng"],"recId":"1840001712","person":[{"display":"Hehlmann, Rüdiger","given":"Rüdiger","family":"Hehlmann","role":"aut"}],"note":["Gesehen am 24.03.2023"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"What is the right dosage of dasatinib for treating chronic myeloid leukaemia?","title_sort":"What is the right dosage of dasatinib for treating chronic myeloid leukaemia?"}],"physDesc":[{"extent":"1 S."}],"id":{"eki":["1840001712"],"doi":["10.1111/bjh.17618"]},"relHost":[{"name":{"displayForm":["ed. R. B. Thompson [u.a.]"]},"recId":"269758941","title":[{"title_sort":"British journal of haematology","subtitle":"BJHaem : an official journal of the British Society for Haematology","title":"British journal of haematology"}],"id":{"zdb":["1475751-5"],"doi":["10.1111/(ISSN)1365-2141"],"eki":["269758941"],"issn":["1365-2141"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Oxford [u.a.] ; Oxford ; Oxford [u.a.]","dateIssuedKey":"1955","dateIssuedDisp":"1955-","publisher":"Wiley-Blackwell ; Blackwell Science ; Blackwell"}],"language":["eng"],"part":{"year":"2021","volume":"194","text":"194(2021), 2, Seite 234","extent":"1","pages":"234","issue":"2"},"pubHistory":["1.1955 -"],"note":["Gesehen am 08.05.08"],"disp":"What is the right dosage of dasatinib for treating chronic myeloid leukaemia?British journal of haematology","type":{"media":"Online-Ressource","bibl":"periodical"},"corporate":[{"role":"isb","display":"British Society for Haematology"},{"display":"European Hematology Association","role":"isb"}],"titleAlt":[{"title":"the official journal of the British Society of Haematology"},{"title":"BJH ; the official journal of the British Society for Haematology"}]}],"origin":[{"dateIssuedDisp":"2021","dateIssuedKey":"2021"}]} 
SRT |a HEHLMANNRUWHATISTHER2021